Top broker names Ramsay Health Care shares as a sell

The Ramsay Health Care Limited (ASX:RHC) share price has been tipped to sink lower over the next 12 months by one leading broker…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ramsay Health Care Limited (ASX: RHC) share price will be on watch this morning after the private hospital operator was the subject of a bearish broker note.

According to a note out of Goldman Sachs, its analysts have retained their sell rating and $57.00 price target on the company's shares.

Considering the Ramsay Health Care share price closed last week at $73.09, this price target implies potential downside of just over 22% during the next 12 months.

Why is Goldman Sachs bearish on Ramsay Health Care?

According to the note, the broker has concerns over the structural issues that are impacting the healthcare sector.

Its analysts said: "Whilst payor pressure is likely less steep without a mandated 2% premium cap, the structural issues prevailing prior to the election result must still be addressed, and we expect continued price/mix erosion through the mid-term."

Goldman notes that for many years Ramsay benefited from mid/high-single digit growth in both volume and price in Australia.

However, due to a series of structural challenges, which are rooted in affordability/efficiency, Goldman believes these levels are unlikely to be achieved again in the medium term.  

"In our view, a 2% premium growth mandate is now unlikely to manifest under the current political regime, but we still expect a downward trajectory as affordability remains a real (and growing problem). Premiums have outpaced inflation for many years consecutively. We believe a period of lower growth/inflation/rates in Australia provides further downside risk."

In light of this, the broker has concerns over Ramsay's growth prospects over the medium to long term.

It added: "RHC is currently growing above industry averages, as corroborated by recent performance and industry feedback. We believe this is achievable due to its scale and market-leading portfolio but, over the long-term we believe it is difficult for any player with such dominant share to sustainably outperform the market, as demonstrated historically. In any case, recent industry data suggests that in-patient volumes are continuing to deteriorate, a trend which RHC will struggle to avoid with >30% share."

Overall, the broker believes these headwinds make Ramsay's shares expensive at the current level and therefore continue to rate them as a sell. 

Ramsay isn't the only healthcare share that Goldman Sachs is bearish on. Last week its analysts downgraded NIB Holdings Limited (ASX: NHF) shares to a sell rating with a $5.63 price target on valuation grounds. The broker also has a sell rating on Medibank Private Ltd (ASX: MPL) shares for similar reasons.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended NIB Holdings Limited and Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Opinions

2 ASX shares I have been buying in 2024!

I’m a believer in the long-term outlook of these stocks.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »